VENN STRATEGIES

VENN STRATEGIES filed a Q3 report for TRIS PHARMA, INC. on October 20, 2025, reporting $70,000 in lobbying income.

Lobbying for TRIS PHARMA, INC. · Biopharmaceutical company

All filings by VENN STRATEGIES · Everything TRIS PHARMA, INC. has reported

Amended

The filer submitted a later report covering this same period, so the amounts here have been replaced. Site totals count only the latest version. See the current filing, posted Oct 20, 2025.

Filing · LD-2 quarterly report Q3 report

Reporting period

3rd Quarter 2025

July 1 - Sep 30 · Posted Oct 20, 2025

Income

$70,000

What the client paid this registrant for the period.

Client based in

New Jersey

Official filing document

Government bodies contacted 2

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 1

Health Issues

Policy activities related to treatment of ADHD.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.